316 related articles for article (PubMed ID: 16549380)
21. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
[TBL] [Abstract][Full Text] [Related]
22. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
23. Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.
Pimenta FC; Miyaji EN; Arêas AP; Oliveira ML; de Andrade AL; Ho PL; Hollingshead SK; Leite LC
Infect Immun; 2006 Aug; 74(8):4939-44. PubMed ID: 16861686
[TBL] [Abstract][Full Text] [Related]
24. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
Bitsaktsis C; Iglesias BV; Li Y; Colino J; Snapper CM; Hollingshead SK; Pham G; Gosselin DR; Gosselin EJ
Infect Immun; 2012 Mar; 80(3):1166-80. PubMed ID: 22158740
[TBL] [Abstract][Full Text] [Related]
25. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.
Yu J; Chen X; Li B; Gu T; Meng X; Kong W; Wu Y
Immunol Res; 2018 Aug; 66(4):528-536. PubMed ID: 30128745
[TBL] [Abstract][Full Text] [Related]
26. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection.
Villena J; Medina M; Raya R; Alvarez S
Can J Microbiol; 2008 Oct; 54(10):845-53. PubMed ID: 18923553
[TBL] [Abstract][Full Text] [Related]
27. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice.
Roche AM; King SJ; Weiser JN
Infect Immun; 2007 May; 75(5):2469-75. PubMed ID: 17339359
[TBL] [Abstract][Full Text] [Related]
28. An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage.
Sun K; Johansen FE; Eckmann L; Metzger DW
J Immunol; 2004 Oct; 173(7):4576-81. PubMed ID: 15383591
[TBL] [Abstract][Full Text] [Related]
29. Transcutaneous immunization with pneumococcal surface protein A in mice.
Nagano H; Kawabata M; Sugita G; Tsuruhara A; Ohori J; Jimura T; Miyashita K; Kurono Y; Tomonaga K; Briles DE; Fujihashi K
Laryngoscope; 2018 Mar; 128(3):E91-E96. PubMed ID: 29226330
[TBL] [Abstract][Full Text] [Related]
30. Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice.
Medina M; Villena J; Vintiñi E; Hebert EM; Raya R; Alvarez S
Infect Immun; 2008 Jun; 76(6):2696-705. PubMed ID: 18390997
[TBL] [Abstract][Full Text] [Related]
31. Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children.
Zhang Q; Choo S; Finn A
Infect Immun; 2002 Oct; 70(10):5363-9. PubMed ID: 12228260
[TBL] [Abstract][Full Text] [Related]
32. Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole-cell inactivated pneumococcal vaccine.
David SC; Laan Z; Minhas V; Chen AY; Davies J; Hirst TR; McColl SR; Alsharifi M; Paton JC
Immunol Cell Biol; 2019 Sep; 97(8):726-739. PubMed ID: 31050022
[TBL] [Abstract][Full Text] [Related]
33. Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age.
Schmid P; Selak S; Keller M; Luhan B; Magyarics Z; Seidel S; Schlick P; Reinisch C; Lingnau K; Nagy E; Grubeck-Loebenstein B
Vaccine; 2011 May; 29(23):3982-9. PubMed ID: 21481328
[TBL] [Abstract][Full Text] [Related]
34. Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
Tostes RO; Rodrigues TC; da Silva JB; Schanoski AS; Oliveira ML; Miyaji EN
PLoS One; 2017; 12(1):e0170157. PubMed ID: 28103277
[TBL] [Abstract][Full Text] [Related]
35. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.
Miyaji EN; Dias WO; Gamberini M; Gebara VC; Schenkman RP; Wild J; Riedl P; Reimann J; Schirmbeck R; Leite LC
Vaccine; 2001 Dec; 20(5-6):805-12. PubMed ID: 11738744
[TBL] [Abstract][Full Text] [Related]
36. Pneumococcal Surface Protein A does not affect the immune responses to a combined diphtheria tetanus and pertussis vaccine in mice.
Lima FA; Miyaji EN; Quintilio W; Raw I; Ho PL; Oliveira ML
Vaccine; 2013 May; 31(20):2465-70. PubMed ID: 23541622
[TBL] [Abstract][Full Text] [Related]
37. Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae.
Shah P; Briles DE; King J; Hale Y; Swiatlo E
Exp Biol Med (Maywood); 2009 Apr; 234(4):403-9. PubMed ID: 19176871
[TBL] [Abstract][Full Text] [Related]
38. Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice.
Vintiñi E; Villena J; Alvarez S; Medina M
Clin Exp Immunol; 2010 Mar; 159(3):351-62. PubMed ID: 20002449
[TBL] [Abstract][Full Text] [Related]
39. Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae.
Medina M; Villena J; Salva S; Vintiñi E; Langella P; Alvarez S
Microbiol Immunol; 2008 Aug; 52(8):399-409. PubMed ID: 18667039
[TBL] [Abstract][Full Text] [Related]
40. Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA.
Ciabattini A; Giomarelli B; Parigi R; Chiavolini D; Pettini E; Aricò B; Giuliani MM; Santini L; Medaglini D; Pozzi G
Vaccine; 2008 Aug; 26(33):4244-50. PubMed ID: 18582996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
